Please do not leave this page until complete. This can take a few moments.
Struggling life science firm Mustang Bio has completed a reverse stock split to avoid having its stock be delisted from the Nasdaq and closed a leased facility in Worcester, exiting the city after nearly a decade of operations.
The firm, which has dealt with a potential delisting from the the Nasdaq Capital Market and layoffs since the beginning of 2024, terminated its lease for 27,043 square feet of space at 377 Plantation St., where it had a presence since 2018. The company will now be headquartered out of a facility in Waltham, according to a Thursday press release announcing the exit and filings with the U.S. Securities and Exchange Commission.
The company will rely on academic partners and future contract manufacturing relationships to support its clinical trials.
The building at 377 Plantation St. is owned by Worcester City Campus Corp., a not-for-profit corporation used to support facility operations at nearby UMass Chan Medical School.
The termination of the lease is expected to save the company $2 million in cash expenses over the next 24 months, with an additional $1 million being raised by selling furniture and equipment at the site to AbbVie, the Delaware-based life science firm with operations at nearby 381 Plantation St. and 100 Research Drive.
Mustang Bio avoided potential delisting from Nasdaq on Jan 15., when it completed a 1-for-50 reverse stock split in order to bring its share price back above $1.
The company’s stock had been trading at 12 cents before the reverse split, which resulted in a new price of $5.55. Mustang Bio’s stock is trading around $1.92 as of Friday morning, well below its 52-week high of $74.50 and its lowest amount since the reverse split.
A firm focused on developing immunotherapies and gene therapies for cancers and other diseases, Mustang Bio was once seeing year-after-year growth, which fueled an expansion of its Worcester footprint.
Eric Casey is the managing editor at Worcester Business Journal, who primarily covers the manufacturing and real estate industries.
Stay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Sign upWorcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
SubscribeWorcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
See Digital EditionStay connected! Every business day, WBJ Daily Report will be delivered to your inbox by noon. It provides a daily update of the area’s most important business news.
Worcester Business Journal provides the top coverage of news, trends, data, politics and personalities of the Central Mass business community. Get the news and information you need from the award-winning writers at WBJ. Don’t miss out - subscribe today.
Worcester Business Journal presents a special commemorative edition celebrating the 300th anniversary of the city of Worcester. This landmark publication covers the city and region’s rich history of growth and innovation.
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
In order to use this feature, we need some information from you. You can also login or register for a free account.
By clicking submit you are agreeing to our cookie usage and Privacy Policy
Already have an account? Login
Already have an account? Login
Want to create an account? Register
This website uses cookies to ensure you get the best experience on our website. Our privacy policy
To ensure the best experience on our website, articles cannot be read without allowing cookies. Please allow cookies to continue reading. Our privacy policy
0 Comments